ObjectiveHealth, a respected leader in conducting clinical research at the point of care, has officially changed the name of its facility in Richmond, Virginia, from GI Select Health Research to ObjectiveHealth Clinical Research. This rebranding reflects the organization’s ongoing commitment to making clinical trials more accessible to patients by bringing research directly into healthcare settings. The updated name also signals a broader scope of research, moving beyond the facility’s previous focus on liver disease to include a wider range of therapeutic areas within the ObjectiveHealth network.
Health Technology Insights: Mass General Brigham Launches Two Cancer MRD Trials
The Richmond site has developed a strong reputation for excellence in gastroenterology research, and although the name has changed, the team remains the same. They will continue offering high-quality, patient-centered clinical trials while leveraging the expanded resources, advanced technology, and support available through the ObjectiveHealth network. As Steve Clemons, CEO of ObjectiveHealth, explains, “This rebranding reflects our mission to increase patient access to more clinical trial options within our service area.”
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup
ObjectiveHealth operates a model that integrates clinical trials into regular medical practice by working closely with physicians nationwide. This approach helps remove obstacles for patients who may not have local access to research opportunities and ensures that new treatments are tested in real-world settings. The Richmond team will maintain strong ties with local healthcare providers and will continue playing a key role in connecting patients with innovative therapies that might otherwise be difficult to access.
For clinical trial sponsors, the Richmond site remains a dependable option, backed by a track record of research success and the advantages of ObjectiveHealth’s technology-driven model. From improving patient matching with trials to ensuring accurate data collection, the integration with ObjectiveHealth positions the Richmond location as an essential part of a growing, nationwide effort to advance medical research.
With this rebrand, ObjectiveHealth continues to push forward in its mission to expand access, improve outcomes, and make clinical research more inclusive by embedding trials within everyday care. The Richmond facility is now better positioned than ever to serve both patients and sponsors as part of a broader movement toward accessible, real-world healthcare innovation.
Health Technology Insights: Patients Prefer Remote Trials with Simple Wearables
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
